Searched for
BIOLOGICS IN INDIA
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Fable 5: Anthropic's latest AI model could transform IT, but at a costAnthropic's Fable 5 AI model showcases advanced agentic coding, capable of autonomous complex task completion and outperforming benchmarks....
- Claude Fable 5 & Mythos 5: Key highlights from Anthropic’s latest launchAnthropic has launched Claude Fable 5, its most capable publicly available AI model, excelling in complex tasks and benchmarks. Alongside i...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Born in Bihar, he became one of the greatest writers in English language, but he was not IndianGeorge Orwell, born Eric Arthur Blair in Motihari, British India, became a celebrated British writer. His classics, Animal Farm and 1984, r...
- This blood test may reveal lung cancer risk long before symptomsA new blood test can predict lung cancer more than five years before diagnosis. This breakthrough offers hope for early detection in India....
- Business as second nature: Biomimicry offers a framework to shift from replication to innovation using natural principles
- Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...
- Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Great Nicobar project commercial enterprise; ecological havoc assured: Congress' Jairam RameshJairam Ramesh, a senior Congress leader, has strongly criticized the Great Nicobar Island Project. He labels it a commercial venture that w...
- Weather swings, monsoon risks, and the growing threat to mango, apple cropsThe agriculture industry has evolved historically through adaptation and resilience, and now it is time to speed up this transformation, em...
- Living in the land of cheater cockroaches takes guts, spunk & moxieTo learn to cheat in India - in exams or real estate, by overcharging in hospitals or fleecing foreign tourists - is to learn how to surviv...
- AI-linked hiring in CDMO industry jumps nearly 3-fold in 2 years: ReportArtificial intelligence skill demand in India's Contract Development and Manufacturing Organisation sector is set to surge. Demand for AI s...
- IMEC, Indo-Pacific routes key to reducing Hormuz dependence: EYIndia is urged to diversify its trade routes and develop new corridors like IMEC and the Indo-Pacific route. This aims to lessen dependence...
- Govt readies contingency plans to counter El Nino threat to kharif season: Shivraj Singh ChouhanThe Indian government is ready for El Nino's impact on the upcoming kharif crop. Contingency plans are being made for affected districts. T...
- Government fully prepared to tackle El Nino impact on kharif crop: ChouhanThe government is ready for El Nino's impact on the upcoming kharif crop. Contingency plans are being made for affected areas.
- True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...
- Biotech startup StrainX Bioworks raises $13 million from Prime Venture, Leo Capital, othersStrainX Bioworks, a synthetic biology and precision fermentation startup, has raised $13 million to advance its biotechnology platform. The...
- IPL Biologicals opens 3rd plant in Vadodara, raises capacity to 7,000 KL/yearIPL Biologicals Ltd has inaugurated its third biological manufacturing facility in Vadodara, Gujarat. This new plant represents a Rs 200 cr...
Load More
